Screening | Study drug pre-treatment phase | Study drug + OIT up-dosing phase | OIT up-dosing without study drug phasea | Early term | Unsched visit | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Visits | V1 | V2 | V3 | V4 | V5j | V6 | V7j | V8 | V9 | V10 | V11 | V12 | V13 | V14 | v15 + … | V20 | v22 + … | PC36n | EoS | ET | UVm | |
Visit week | Scr | W-8 | W-6 | W-4 | W-2 | D1 | W2 | W4 | W6 | W8 | W10 | W12 | q2w | W24 | q2w | W36 | W52+ | |||||
Time window | No more than 7 days apart | Max 90 days after V1 | ±4 days | ±4 days | e | ±7 days | e | ±7days | e | ±7 days | ±7 days | |||||||||||
Informed consent/assent | X | |||||||||||||||||||||
Check eligibility criteria | X | X | ||||||||||||||||||||
QoL questionnaire* | X | X | X | X | X | |||||||||||||||||
Treatment-related cost evaluation questionnaire** | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Demographics | X | |||||||||||||||||||||
Medical history | X | |||||||||||||||||||||
Allergy history | X | |||||||||||||||||||||
Weight and heightb | X | X | X | X | X | Xb | Xb | X | Xb | X | Xb | X | X | |||||||||
Vital signs | X | Xh | Xh | Xh | ||||||||||||||||||
Complete Physical Examination | X | X | X | |||||||||||||||||||
Brief Physical Examination | Xi | Xi | X | X | X | X | Xi | X | X | X | X | X | X | X | X | X | X | |||||
Skin Prick Test | X | X | X | X | X | X | ||||||||||||||||
Blood sampling | X | X | Xo | X | X | X | X | |||||||||||||||
Optional stool sample collection | Xp | Xq | X | X | X | |||||||||||||||||
Urine pregnancy testc | X | X | X | X | X | |||||||||||||||||
Spirometry | X | |||||||||||||||||||||
Peak expiratory flow (PEF) | X | X | X | X | ||||||||||||||||||
Prior/concomitant medicationd | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Adverse event collection (AE) | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
Double-blind placebo-controlled challenge | X | X | ||||||||||||||||||||
Randomization | X | |||||||||||||||||||||
Study drug administratione | X | Xj | X | Xj | X | Xj | Xj | Xj | ||||||||||||||
Initial food escalation | X | |||||||||||||||||||||
Epinephrine auto-injector trainingf | X | |||||||||||||||||||||
Review OIT action planf | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||
Up-dosingg | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Food treatment mix dispensation | X | X | X | X | X | X | X | X | X | X | X | |||||||||||
Review and dispense of study home dosing diary | X | X | X | X | X | X | X | X | X | X | X | X | X | X |